Cargando…
Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins
Early and persistent activation of complement is considered to play a key role in the pathogenesis of COVID-19. Complement activation products orchestrate a proinflammatory environment that might be critical for the induction and maintenance of a severe inflammatory response to SARS-CoV-2 by recruit...
Autores principales: | Ali, Youssif M., Ferrari, Matteo, Lynch, Nicholas J., Yaseen, Sadam, Dudler, Thomas, Gragerov, Sasha, Demopulos, Gregory, Heeney, Jonathan L., Schwaeble, Wilhelm J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287855/ https://www.ncbi.nlm.nih.gov/pubmed/34290717 http://dx.doi.org/10.3389/fimmu.2021.714511 |
Ejemplares similares
-
Inhibition of the lectin pathway of complement activation reduces LPS-induced acute respiratory distress syndrome in mice
por: Ali, Youssif M., et al.
Publicado: (2023) -
Secondary Complement Deficiency Impairs Anti-Microbial Immunity to Klebsiella pneumoniae and Staphylococcus aureus During Severe Acute COVID-19
por: Ali, Youssif M., et al.
Publicado: (2022) -
Absence of the Lectin Activation Pathway of Complement Ameliorates Proteinuria-Induced Renal Injury
por: Alghadban, Samy, et al.
Publicado: (2019) -
Inhibition of the lectin pathway of complement ameliorates hypocomplementemia and restores serum bactericidal activity in patients with severe COVID‐19
por: Lynch, Nicholas J., et al.
Publicado: (2022) -
Development and characterization of narsoplimab, a selective MASP-2 inhibitor, for the treatment of lectin-pathway–mediated disorders
por: Dudler, Thomas, et al.
Publicado: (2023)